CARERATINGCare Ratings

₹1605+0.02%

Market Cap

₹4,802.03 Cr

Stock P/E

33.75

ROCE

25.52%

ROE

18.51%

Book Value

₹275.74

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Foreign Investors

Domestic Investors

Public

From Last Concall

POSITIVES

•
FY25 stand-alone income from operations reached a record high, up 19% YoY to 336.7 crore, led by initial ratings for capital market instruments, securitizations and bank debt.
•
Consolidated revenue from operations for FY25 rose 21% YoY to 402.3 crore, marking strong broad-based performance across domestic and overseas ratings and higher contribution from non-ratings.

NEGATIVES

•
Near-term ESG investments are expected to incur losses, with expenditures likely exceeding revenues in the near term.
•
Macro headwinds and policy/geopolitical uncertainties could temper growth into FY26.

Peers Summary

Sector Leader

Care Ratings Ltd. shows strong revenue growth and profitability metrics compared to its peers, positioning it as a leader in the Ratings industry. It boasts the highest revenue growth and strong EBITDA margins, while also maintaining a healthy debt position. However, it is moderately valued compared to its peers, suggesting potential for growth at a reasonable price.

Key Points

• Care Ratings Ltd. leads in revenue growth YoY (21.3%) and profitability with a PAT margin of 34.80%.
• CRISIL Ltd. holds the highest ROE (29.15%) and EBITDA margin (30.84%) but is the most overvalued with a PE of 50.64.
• ICRA Ltd. shows strong EPS growth and low PEG ratio, indicating it may be undervalued relative to its growth potential.

Top Performers

Care Ratings Ltd.

Highest revenue growth YoY (21.3%) and solid PAT margin (34.80%) along with low debt.

ICRA Ltd.

Strong EPS performance (176.15) and efficiency with the lowest debt equity ratio (0.0018).

Explore

Watchlists

Command Palette